Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Working Capital/Sales

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 2.193.163.704.375.17

What is the latest Working Capital/Sales ratio of NEULAND LABORATORIES ?

The latest Working Capital/Sales ratio of NEULAND LABORATORIES is 2.19 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.19
Mar20243.16
Mar20233.70
Mar20224.37
Mar20215.17

How is Working Capital/Sales of NEULAND LABORATORIES Trending?

Years Working Capital/Sales % Change
Mar2025 2.19
-30.70
Mar2024 3.16
-14.59
Mar2023 3.7
-15.33
Mar2022 4.37
-15.47
Mar2021 5.17 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Working Capital/Sales ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,915.8 Cr 3% -2.9% 11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

3%

-2.9%

11.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses